Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

The incidence of inherited porphyrias in Europe.

Elder G, Harper P, Badminton M, Sandberg S, Deybach JC.

J Inherit Metab Dis. 2013 Sep;36(5):849-57. doi: 10.1007/s10545-012-9544-4.

PMID:
23114748
2.
3.

A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.

Zhang J, Yasuda M, Desnick RJ, Balwani M, Bishop D, Yu C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 15;879(24):2389-96. doi: 10.1016/j.jchromb.2011.06.034.

4.

Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity.

Hift RJ, Thunell S, Brun A.

Pharmacol Ther. 2011 Nov;132(2):158-69. doi: 10.1016/j.pharmthera.2011.06.001. Review.

PMID:
21704073
5.

Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.

Dowman JK, Gunson BK, Mirza DF, Bramhall SR, Badminton MN, Newsome PN; UK Liver Selection and Allocation Working Party..

Liver Transpl. 2012 Feb;18(2):195-200. doi: 10.1002/lt.22345.

6.

Liver transplantation from donors with acute intermittent porphyria.

Dowman JK, Gunson BK, Bramhall S, Badminton MN, Newsome PN.

Ann Intern Med. 2011 Apr 19;154(8):571-2. doi: 10.7326/0003-4819-154-8-201104190-00015. No abstract available. Erratum in: Ann Intern Med. 2011 Apr 19;154(8):572. Ann Intern Med. 2011 Jun 21;154(12):848.

PMID:
21502660
7.

Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa.

Deybach JC, Puy H.

J Intern Med. 2011 May;269(5):521-4. doi: 10.1111/j.1365-2796.2011.02358.x. No abstract available.

8.

Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden.

Innala E, Andersson C.

J Intern Med. 2011 May;269(5):538-45. doi: 10.1111/j.1365-2796.2010.02335.x.

9.

A retrospective analysis of outcome of pregnancy in patients with acute porphyria.

Marsden JT, Rees DC.

J Inherit Metab Dis. 2010 Oct;33(5):591-6. doi: 10.1007/s10545-010-9142-2.

PMID:
20567908
10.

Acute Intermittent Porphyria.

Whatley SD, Badminton MN.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2005 Sep 27 [updated 2013 Feb 7].

11.

Porphyrias.

Puy H, Gouya L, Deybach JC.

Lancet. 2010 Mar 13;375(9718):924-37. doi: 10.1016/S0140-6736(09)61925-5. Review.

PMID:
20226990
12.

Combined liver and kidney transplantation in acute intermittent porphyria.

Wahlin S, Harper P, Sardh E, Andersson C, Andersson DE, Ericzon BG.

Transpl Int. 2010 Jun;23(6):e18-21. doi: 10.1111/j.1432-2277.2009.01035.x.

13.

Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria.

Innala E, Bäckström T, Bixo M, Andersson C.

Acta Obstet Gynecol Scand. 2010;89(1):95-100. doi: 10.3109/00016340903390729.

PMID:
20021268
14.

Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene.

Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN.

Clin Chem. 2009 Jul;55(7):1406-14. doi: 10.1373/clinchem.2008.122564.

15.

Neurological manifestations of acute intermittent porphyria.

Pischik E, Kauppinen R.

Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):72-83. Review.

PMID:
19268005
16.

Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria.

Gill R, Kolstoe SE, Mohammed F, Al D-Bass A, Mosely JE, Sarwar M, Cooper JB, Wood SP, Shoolingin-Jordan PM.

Biochem J. 2009 Apr 28;420(1):17-25. doi: 10.1042/BJ20082077.

PMID:
19207107
17.

Liver transplantation for porphyria: who, when, and how?

Seth AK, Badminton MN, Mirza D, Russell S, Elias E.

Liver Transpl. 2007 Sep;13(9):1219-27. Review.

18.

Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias.

Thunell S, Pomp E, Brun A.

Br J Clin Pharmacol. 2007 Nov;64(5):668-79. Review.

19.

(Far) Outside the box: genomic approach to acute porphyria.

Thunell S.

Physiol Res. 2006;55 Suppl 2:S43-66. Review.

20.

Treatment of an acute attack of porphyria during pregnancy.

Badminton MN, Deybach JC.

Eur J Neurol. 2006 Jun;13(6):668-9. No abstract available.

PMID:
16796597
Items per page

Supplemental Content

Support Center